Search research articles
Contact Us
Filters
Showing results (41-50 of 177) with videos related to
Page
of 18
Sort By:
Frontiers in Immunology
|
October 10, 2022
Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma
Xiaozhuo Gao, Bo Gao, Shenglong Li
Journal of Bone Oncology
|
February 12, 2019
Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial
Shenglong Li, Peng Chen, Qiankun Yang
Frontiers in Bioengineering and Biotechnology
|
January 28, 2022
Advances in the Application of Exosomes Identification Using Surface-Enhanced Raman Spectroscopy for the Early Detection of Cancers
Lu Yang, Jingyuan Jia, Shenglong Li
International Journal of Bioprinting
|
September 15, 2022
Advances of 3D Printing in Vascularized Organ Construction
Shenglong Li, Siyu Liu, Xiaohong Wang
Molecular Cancer
|
August 31, 2025
Engineered iron oxide nanoplatforms: reprogramming immunosuppressive niches for precision cancer theranostics
Chao Yang, Shenglong Li, Liming Wang
Molecular Cancer
|
September 13, 2024
Correction: Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers: the "all-around warrior" in immunotherapy
Qiang Liu, Yujing Guan, Shenglong Li
Journal of Bone Oncology
|
March 30, 2026
Corrigendum to "Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial" [J. Bone Oncol. 35 (2022) 100441]
Jiaji Yue, Wei Sun, Shenglong Li
Nephron
|
July 2, 2026
The Impact of High-Altitude Acclimatization on Frontal Lobe Executive Function: The Mediating Effect of Creatinine
Hongyan Li, Yonghao Ou, Shenglong Li
Journal of Bone Oncology
|
July 8, 2022
Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial
Jiaji Yue, Wei Sun, Shenglong Li
Alimentary Pharmacology & Therapeutics
|
November 11, 2025
Letter on 'Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis'
Yi Pei, Runze Jiang, Shenglong Li
Page
of 18
Search research articles
Search
Showing results (41-50 of 177) with videos related to
Sort By:
Page
of 18
Frontiers in Immunology
|
October 10, 2022
Extracellular vesicles: A new diagnostic biomarker and targeted drug in osteosarcoma
Xiaozhuo Gao, Bo Gao, Shenglong Li
Journal of Bone Oncology
|
February 12, 2019
Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial
Shenglong Li, Peng Chen, Qiankun Yang
Frontiers in Bioengineering and Biotechnology
|
January 28, 2022
Advances in the Application of Exosomes Identification Using Surface-Enhanced Raman Spectroscopy for the Early Detection of Cancers
Lu Yang, Jingyuan Jia, Shenglong Li
International Journal of Bioprinting
|
September 15, 2022
Advances of 3D Printing in Vascularized Organ Construction
Shenglong Li, Siyu Liu, Xiaohong Wang
Molecular Cancer
|
August 31, 2025
Engineered iron oxide nanoplatforms: reprogramming immunosuppressive niches for precision cancer theranostics
Chao Yang, Shenglong Li, Liming Wang
Molecular Cancer
|
September 13, 2024
Correction: Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers: the "all-around warrior" in immunotherapy
Qiang Liu, Yujing Guan, Shenglong Li
Journal of Bone Oncology
|
March 30, 2026
Corrigendum to "Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial" [J. Bone Oncol. 35 (2022) 100441]
Jiaji Yue, Wei Sun, Shenglong Li
Nephron
|
July 2, 2026
The Impact of High-Altitude Acclimatization on Frontal Lobe Executive Function: The Mediating Effect of Creatinine
Hongyan Li, Yonghao Ou, Shenglong Li
Journal of Bone Oncology
|
July 8, 2022
Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial
Jiaji Yue, Wei Sun, Shenglong Li
Alimentary Pharmacology & Therapeutics
|
November 11, 2025
Letter on 'Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis'
Yi Pei, Runze Jiang, Shenglong Li
Page
of 18